We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

02 Jun 2026 - 04 Jun 2026
17 Jun 2026 - 19 Jun 2026

Respironics to Market New Nebulizer System

By HospiMedica staff writers
Posted on 20 Oct 2004
A new nebulizer system that offers improved pulmonary drug delivery efficiency and has the potential to reduce drug and personnel costs in the critical care setting will be marketed worldwide by Respironics, Inc. More...
(Murrysville, PA, USA) under a nonexclusive agreement with Aerogen, Inc. (Mountain View, CA, USA).

Respironics will market and distribute the nebulizer with its new and existing ventilator support systems. The nebulizer, called Aeroneb Pro, incorporates Aerogen's proprietary OnQ aerosol generator, designed to improve the delivery of drugs for respiratory disorders in a critical care setting. Respironics is a leading developer, manufacturer, and distributor of products and programs that serve global sleep and respiratory markets.

"We're pleased to be working with Respironics, a worldwide leader in the development and commercialization of respiratory products,” noted Dr. Jane Shaw, chairman and CEO of Aerogen. "This relationship will expand the market penetration of our Aeroneb Pro for aerosolized delivery of respiratory therapies in the critical care setting.”

Aerogen develops drug-device combination aerosol products based on its OnQ generator technology to improve treatment of respiratory disorders. The company has reported the results of a phase 2 clinical study evaluating delivery of aerosolized amikacin for the treatment of ventilator-associated pneumonia. Additional drugs targeting improved respiratory therapy are in the feasibility and preclinical stages of development.





Related Links:
Respironics
Aerogen

Gold Member
Neonatal Heel Incision Device
Tenderfoot
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Hybrid Arch Device
Neo EDE
Syringe Pump
SP50 Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The Elyra TFL System uses thulium fiber laser technology for efficient stone dusting and reduced stone migration, with an air-cooled design for quieter, more compact operation (photo courtesy of BD

BD Launches Elyra Laser Platform for Kidney Stone and Soft Tissue Procedures

BD (Becton, Dickinson and Company) has introduced the Elyra Thulium Fiber Laser (TFL) System, an advanced laser platform developed to complete its kidney stone care portfolio for urology teams.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.